XML 44 R30.htm IDEA: XBRL DOCUMENT v2.4.1.9
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2014
STOCKHOLDERS' EQUITY  
Schedule of warrants outstanding to purchase common stock and classified as equity

 

As of December 31, 2014, the following warrants to purchase our common stock were outstanding and classified as equity:

                                                                                                                                                                                    

Issuance Date

 

Exercise
Price

 

Number of
Shares

 

Exercisable
Date

 

Expiration
Date

August 2011(1)

 

$

3.98 

 

 

537,893 

 

August 2011

 

August 2021

April 2005

 

$

3.75 

 

 

470,000 

 

April 2005

 

April 2015

​  

​  

 

 

 

 

 

 

1,007,893 

 

 

 

 

​  

​  

​  

​  

​  


(1)

In connection with each disbursement under the loan agreement with CIRM, we were obligated to issue to CIRM a warrant to purchase Geron common stock. Such warrants and the underlying common stock were unregistered. We have no further obligations to issue any additional warrants to CIRM. In December 2014, CIRM exercised a warrant to purchase 461,382 shares of our common stock utilizing the net exercise provision in the warrant resulting in the issuance of 168,039 shares of our common stock.

 

Schedule of aggregate option and award activity

 

 

 

 

 

Outstanding Options

 

 

 

Shares
Available
For Grant

 

Number of
Shares

 

Weighted Average
Exercise Price
Per Share

 

Weighted Average
Remaining
Contractual Life
(In years)

 

Aggregate
Intrinsic
Value
(In thousands)

 

Balance at December 31, 2013

 

 

16,207,250

 

 

15,576,216

 

$

3.04

 

 

 

 

$

33,798

 

Options granted

 

 

(5,658,931

)

 

5,658,931

 

$

4.85

 

 

 

 

 

 

 

Awards granted

 

 

(59,330

)

 

 

$

 

 

 

 

 

 

 

Options exercised

 

 

 

 

(662,626

)

$

1.94

 

 

 

 

 

 

 

Options cancelled/forfeited

 

 

3,613,577

 

 

(3,613,577

)

$

5.48

 

 

 

 

 

 

 

Awards cancelled/forfeited

 

 

142,375

 

 

 

$

 

 

 

 

 

 

 

2006 Directors Plan termination

 

 

(860,058

)

 

 

$

 

 

 

 

 

 

 

​  

​  

​  

​  

Balance at December 31, 2014

 

 

13,384,883

 

 

16,958,944

 

$

3.16

 

 

7.38

 

$

16,038

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

Options exercisable at December 31, 2014

 

 

 

 

 

9,129,576

 

$

3.12

 

 

6.47

 

$

9,231

 

​  

​  

​  

​  

​  

Options fully vested and expected to vest at December 31, 2014

 

 

 

 

 

16,225,022

 

$

3.14

 

 

7.32

 

$

15,546

 

​  

​  

​  

​  

​  

 

Schedule of information about stock options outstanding by exercise price range

 

        Information about stock options outstanding as of December 31, 2014 is as follows:

                                                                                                                                                                                    

 

 

Options Outstanding

 

Exercise Price Range

 

Number of
Shares

 

Weighted Average
Exercise Price
Per Share

 

Weighted Average
Remaining
Contractual Life
(In years)

 

$1.10 - $1.50

 

 

4,284,937 

 

$

1.42 

 

 

7.41 

 

$1.51 - $2.14

 

 

4,278,382 

 

$

1.64 

 

 

7.84 

 

$2.16 - $5.01

 

 

5,376,639 

 

$

4.29 

 

 

7.91 

 

$5.05 - $9.32

 

 

3,018,986 

 

$

5.80 

 

 

5.72 

 

​  

​  

$1.10 - $9.32

 

 

16,958,944 

 

$

3.16 

 

 

7.38 

 

​  

​  

​  

​  

​  

 

Schedule of aggregate restricted stock activity

 

 

 

Number of
Shares

 

Weighted
Average
Grant Date
Fair Value
Per Share

 

Weighted Average
Remaining
Contractual Term
(In years)

 

Non-vested restricted stock at December 31, 2013

 

 

409,437

 

$

4.84

 

 

0.82

 

Granted

 

 

59,330

 

$

2.67

 

 

 

 

Vested

 

 

(265,422

)

$

4.47

 

 

 

 

Cancelled/forfeited

 

 

(142,375

)

$

4.66

 

 

 

 

​  

​  

Non-vested restricted stock at December 31, 2014

 

 

60,970

 

$

4.73

 

 

0.37

 

​  

​  

​  

​  

​  

 

Summary of allocation of stock-based compensation expense related to share-based payment awards

 

 

 

Year Ended December 31,

 

(In thousands)

 

2014

 

2013

 

2012

 

Research and development

 

$

2,545 

 

$

1,741 

 

$

2,336 

 

Restructuring charges

 

 

 

 

28 

 

 

107 

 

General and administrative

 

 

5,113 

 

 

2,666 

 

 

2,868 

 

​  

​  

​  

​  

​  

​  

Stock-based compensation expense included in operating expenses

 

$

7,658 

 

$

4,435 

 

$

5,311 

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

 

Schedule of assumptions used to estimate the fair value of stock options granted

 

 

 

2014

 

2013

 

2012

Dividend yield

 

0%

 

0%

 

0%

Expected volatility range

 

0.898 to 0.922

 

0.742 to 0.792

 

0.631 to 0.740

Risk-free interest rate range

 

1.64% to 1.92%

 

0.80% to 1.97%

 

0.81% to 1.25%

Expected term

 

5.5 yrs

 

6 yrs

 

6 yrs

 

Schedule of assumptions used to estimate the fair value of employee stock purchases under the Purchase Plans

 

 

 

2014

 

2013

 

2012

Dividend yield

 

0%

 

0%

 

0%

Expected volatility range

 

0.835 to 1.666

 

0.506 to 1.391

 

0.458 to 0.774

Risk-free interest rate range

 

0.06% to 0.15%

 

0.09% to 0.21%

 

0.06% to 0.21%

Expected term range

 

6 mos to 12 mos

 

6 mos to 12 mos

 

6 mos to 12 mos

 

Schedule of common stock reserved for future issuance

 

        Common stock reserved for future issuance as of December 31, 2014 is as follows:

                                                                                                                                                                                    

Outstanding stock options

 

 

16,958,944 

 

Options and awards available for grant

 

 

13,384,883 

 

Employee stock purchase plan

 

 

975,625 

 

Warrants outstanding

 

 

1,007,893 

 

​  

​  

Total

 

 

32,327,345 

 

​  

​  

​  

​  

​